<DOC>
	<DOCNO>NCT01766323</DOCNO>
	<brief_summary>Oral morphine often utilized convenient effective method achieve palliation pain terminally ill cancer patient . However , effective dos , majority patient experience undue amount excessive sleepiness . Given generally low expect survival period among patient population , fact morphine cause patient spend significant period remain life sleep , often unacceptable patient family . Given proven benefit modafinil condition characterize excessive sleepiness ( narcolepsy shift-work disorder ) , investigator design prospective placebo control randomized trial addition modafinil dose 200mg per day ( two divide dos ) eligible patient randomization .</brief_summary>
	<brief_title>Palliative Morphine With Without Concurrent Modafinil</brief_title>
	<detailed_description />
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<criteria>Diagnosed confirmed malignancy Able orally consume tablet Blood Pressure : Systolic &lt; 144mmHg ; Diastolic &lt; 92mmHg Normal blood sugar No active systemic infection Consenting Oral morphine consume part terminal symptom palliation Candidates receive oral morphine temporary pain management , potential candidate radical curative approach future Poor performance status ( Karnofsky Performance Status score &lt; 50 ) Prior history hypertension , diabetes , tuberculosis , epilepsy Prior history psychiatric neurological illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Morphine</keyword>
	<keyword>Palliation</keyword>
	<keyword>Cancer</keyword>
	<keyword>Hospice</keyword>
	<keyword>Sleepiness</keyword>
	<keyword>Modafinil</keyword>
</DOC>